The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jan. 23, 2018

Filed:

Jun. 14, 2016
Applicant:

Topcon Medical Laser Systems, Inc., Santa Clara, CA (US);

Inventors:

Daniel V. Palanker, Sunnyvale, CA (US);

Dan Andersen, Menlo Park, CA (US);

Assignee:

Topcon Medical Laser Systems, Inc., Santa Clara, CA (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61B 19/00 (2006.01); A61B 18/18 (2006.01); A61F 9/008 (2006.01); A61B 18/20 (2006.01); A61N 5/06 (2006.01); A61B 90/00 (2016.01); A61B 3/10 (2006.01);
U.S. Cl.
CPC ...
A61F 9/00821 (2013.01); A61B 18/20 (2013.01); A61F 9/008 (2013.01); A61N 5/0622 (2013.01); A61B 3/102 (2013.01); A61B 90/361 (2016.02); A61B 2018/20351 (2017.05); A61F 2009/00851 (2013.01); A61F 2009/00855 (2013.01); A61F 2009/00863 (2013.01); A61F 2009/00868 (2013.01); A61F 2009/00885 (2013.01); A61F 2009/00897 (2013.01);
Abstract

A system and method for treating ophthalmic target tissue, including a light source for generating a beam of light, a beam delivery system that includes a scanner for generating patterns, and a controller for controlling the light source and delivery system to create a dosimetry pattern of the light beam on the ophthalmic target tissue. One or more dosage parameters of the light beam vary within the dosimetry pattern, to create varying exposures on the target tissue. A visualization device observes lesions formed on the ophthalmic target tissue by the dosimetry pattern. The controller selects dosage parameters for the treatment beam based upon the lesions resulting from the dosimetry pattern, either automatically or in response to user input, so that a desired clinical effect is achieved by selecting the character of the lesions as determined by the dosimetry pattern lesions.


Find Patent Forward Citations

Loading…